Alyeska Investment Group »

Vbi Vaccines shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Vbi Vaccines (VBIV) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Vbi Vaccines

Tip: Access up to 7 years of quarterly data

All positions including Vbi Vaccines held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vbi Vaccines by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $828k 1.4M 0.59
2023-09-30 $985k 1.5M 0.67

More positions owned by Alyeska Investment Group

Meta Platforms Cl A (META)
Aercap Holdings Nv SHS (AER)
Take-Two Interactive Software (TTWO)
Epam Systems (EPAM)
Dollar General (DG)
Paycom Software (PAYC)
Twilio Cl A (TWLO)
Burlington Stores (BURL)
Lauder Estee Cos Cl A (EL)
Adobe Systems Incorporated (ADBE)
Oracle Corporation (ORCL)
Autodesk (ADSK)
Xylem (XYL)
Ulta Salon, Cosmetics & Fragrance (ULTA)
Amazon (AMZN)

View all positions for Alyeska Investment Group

Top funds holding Vbi Vaccines

Alyeska Investment Group
Perceptive Advisors
Vanguard Group
Cambridge Investment Research Advisors
Citadel Advisors
Goldman Sachs Group
Alpine Partners VI
Two Sigma Securities
Millennium Management
Warberg Asset Management
Captrust Financial Advisors
Steward Partners Investment Advisory
Wetzel Investment Advisors
Royal Bank of Canada
UBS Group

View all funds holding Vbi Vaccines